HTATIP2 and esophageal squamous cell carcinoma: Log-rank test showed that ESCC patients with low TIP30 expression experienced poor overall survival (OS) than patients with high TIP30 expression (median survival time, 29 months vs. 49 months; P < 0.001; Fig. 6E).